Description: Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company's sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia's; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Home Page: www.illumina.com
ILMN Technical Analysis
5200 Illumina Way
San Diego,
CA
92122
United States
Phone:
858 202 4500
Officers
Name | Title |
---|---|
Mr. Francis A. deSouza | CEO & Director |
Dr. Alexander Aravanis M.D., Ph.D. | CTO & Head of Research and Product Devel. |
Mr. Charles E. Dadswell | Sr. VP, Gen. Counsel & Sec. |
Ms. Susan H. Tousi | Chief Commercial Officer |
Stephanie Campos | Pres |
Dr. Joydeep Goswami M.B.A., Ph.D. | Chief Strategy & Corp. Devel. Officer and Interim CFO |
Mr. Kevin Carl Pegels | Chief of Global Operations |
Mr. Scott Ericksen | VP & Chief Accounting Officer |
Ms. Carissa Rollins | Chief Information Officer |
Ms. Sallilyn Schwartz | VP of Investor Relations |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 72.9927 |
---|---|
Trailing PE: | 46.6914 |
Price-to-Book MRQ: | 4.9071 |
Price-to-Sales TTM: | 6.9433 |
IPO Date: | 2000-07-28 |
Fiscal Year End: | December |
Full Time Employees: | 9800 |